首页> 美国卫生研究院文献>Hepatitis Monthly >The Efficacy of Add-on Telbivudine Versus Switching to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients With Poor Responses to Adefovir

【2h】

The Efficacy of Add-on Telbivudine Versus Switching to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients With Poor Responses to Adefovir

机译：替比夫定加用聚乙二醇干扰素Alfa-2a对慢性乙型肝炎对阿德福韦反应较差的患者的疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:There are limited options for chronic hepatitis B (CHB) patients who have poor responses to adefovir (ADV).

机译：背景：对于阿德福韦（ADV）反应不良的慢性乙型肝炎（CHB）患者的选择有限。

著录项

期刊名称 Hepatitis Monthly
作者
Xin Wei; Chao Fan; Yun Zhou; Wenzhen Kang; Jiuping Wang; Li Sun; Linxu Wang; Meijuan Peng; Jianqi Lian; Zhansheng Jia; Chunqiu Hao;
展开▼
作者单位

展开▼
年(卷),期 2016(16),1
年度 2016
页码 e31278
总页数 7
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词
Hepatitis B Chronic; Drug Therapy; Biomarkers Pharmacological; Adefovir; Telbivudine; Peginterferon Alfa-2a;

机译：乙型肝炎;慢性;药物治疗;生物标志物;药理学;阿德福韦;替比夫定;聚乙二醇干扰素Alfa-2a;

相似文献

外文文献
中文文献
专利

1. The Efficacy of Add-on Telbivudine Versus Switching to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients With Poor Responses to Adefovir [J] . Xin Wei, Chao Fan, Yun Zhou, Hepatitis Monthly . 2016,第1期

机译：加用替比夫定与转用聚乙二醇化干扰素Alfa-2a在对阿德福韦反应较差的慢性乙型肝炎患者中的疗效
2. Sustained efficacy of adefovir add-on therapy in chronic hepatitis B patient with a poor virological response to peginterferon alfa [J] . WangY.-X., ZhengS.-M., ZhangY., Scandinavian journal of gastroenterology. . 2013,第2期

机译：阿德福韦联合疗法在慢性乙型肝炎患者中对聚乙二醇干扰素α的病毒学应答较差的持续疗效
3. Efficacy of telbivudine treatment for hepatitis B e antigen-positive chronic hepatitis B patients with poor response to adefovir dipivoxil [J] . LiY., ZhangY., WangJ.-P., Journal of viral hepatitis. . 2013,第Suppla1期

机译：替比夫定治疗对阿德福韦酯不良反应不良的慢性乙型肝炎e抗原阳性的慢性乙型肝炎患者的疗效
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C. [D] . Phillips, Frances Hinshaw. 2011

机译：接受聚乙二醇干扰素和利巴韦林抗病毒治疗的慢性丙型肝炎退伍军人依从性的含义。
6. Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study) [O] . Hye Won Lee, Jun Yong Park, Beom Kyung Kim, 2016

机译：在慢性乙型肝炎患者中由于对核苷类似物的耐药性而对基于阿德福韦的联合抢救治疗表现出欠佳反应的慢性乙型肝炎患者从阿德福韦换用替诺福韦的疗效（SATIS研究）
7. PL-009 Combination of telbivudine and adefovir dipivoxil therapy in chronic hepatitis B patients with poor response to adefovir dipivoxil monotherapy [O] . Chen E.-Q., Zhou T.-Y., Tang H. 2010

机译：PL-009替比夫定联合阿德福韦酯治疗慢性乙型肝炎患者对阿德福韦酯单一治疗反应差

The Efficacy of Add-on Telbivudine Versus Switching to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients With Poor Responses to Adefovir

摘要

著录项

相似文献

相关主题

期刊订阅